Al-Amin Ahmed, Rolnik Daniel Lorber, Black Carin, White Adrienne, Stolarek Caroline, Brennecke Shaun, da Silva Costa Fabricio
Pauline Gandel Imaging Centre, Royal Women's Hospital, Melbourne, Victoria, Australia.
Monash Ultrasound for Women, Clayton, Victoria, Australia.
Aust N Z J Obstet Gynaecol. 2018 Apr;58(2):192-196. doi: 10.1111/ajo.12689. Epub 2017 Aug 29.
To compare the performance of three different screening methods (National Institute for Health and Clinical Excellence (NICE) guidelines, American College of Obstetricians and Gynecologists (ACOG) recommendations and Fetal Medicine Foundation (FMF) algorithm) for second trimester prediction of preeclampsia.
This was a prospective non-intervention study in singleton pregnancies, including women attending for second trimester morphologic ultrasound at 19-22 weeks. Maternal characteristics, medical history, mean arterial pressure and mean uterine artery Doppler pulsatility index were recorded and used for risk assessment. Outcomes measured were preeclampsia with delivery before 34, before 37 and after 37 weeks gestation. Detection rates, false positive rates and positive likelihood ratios were calculated, and receiver operating characteristic curves were produced.
We screened 543 women during the study. The incidence of preeclampsia before 34, before 37 and after 37 weeks was 0.5, 1.4 and 3.4%, respectively. Detection rates for prediction of preterm preeclampsia were 75% (95% CI 34.9-96.8), 87% (95% CI 47.3-99.6), 100% (95% CI 63.0-100) and 100% (95% CI 63.0-100) for NICE guidelines, ACOG recommendations, FMF algorithm with a 1:100 cut-off and FMF algorithm at 1:60 cut-off, respectively. False positive rates were, 22, 67, 19 and 12% for NICE guidelines, ACOG recommendations, FMF algorithm with a 1:100 cut-off and FMF algorithm at 1:60 cut-off, respectively.
Second trimester combined screening for preterm preeclampsia by maternal history, mean arterial pressure and mean uterine artery Doppler pulsatility index (FMF algorithm) was superior to screening by maternal factors alone (NICE guidelines and ACOG recommendations).
比较三种不同筛查方法(英国国家卫生与临床优化研究所(NICE)指南、美国妇产科医师学会(ACOG)建议和胎儿医学基金会(FMF)算法)在孕中期预测子痫前期的表现。
这是一项针对单胎妊娠的前瞻性非干预性研究,纳入在孕19 - 22周进行孕中期形态学超声检查的女性。记录产妇特征、病史、平均动脉压和平均子宫动脉多普勒搏动指数,并用于风险评估。测量的结局指标为妊娠34周前、37周前和37周后分娩的子痫前期。计算检测率、假阳性率和阳性似然比,并绘制受试者工作特征曲线。
研究期间我们筛查了543名女性。妊娠34周前、37周前和37周后子痫前期的发生率分别为0.5%、1.4%和3.4%。对于早产子痫前期预测的检测率,NICE指南为75%(95%可信区间34.9 - 96.8),ACOG建议为87%(95%可信区间47.3 - 99.6),FMF算法截断值为1:100时为100%(95%可信区间63.0 - 100),FMF算法截断值为1:60时为100%(95%可信区间63.0 - 100)。假阳性率,NICE指南为22%,ACOG建议为67%,FMF算法截断值为1:100时为19%,FMF算法截断值为1:60时为12%。
通过产妇病史、平均动脉压和平均子宫动脉多普勒搏动指数(FMF算法)在孕中期联合筛查早产子痫前期优于仅通过产妇因素进行筛查(NICE指南和ACOG建议)。